Compounds > cytarabine

cytarabine and cyclin d1

cytarabine has been researched along with cyclin d1 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Hirose, M; Kuroda, Y1
Geller, HM; Greene, LA; Morris, EJ; Padmanabhan, J; Park, DS; Shelanski, ML1
Koistinen, P; Savolainen, ER; Siitonen, T1
Bader, Y; Bernhaus, A; Fritzer-Szekeres, M; Gueorguieva, M; Krupitza, G; Leisser, C; Mader, RM; Madlener, S; Maier, S; Richter, S; Saiko, P; Schott, H; Strasser, S; Szekeres, T; Wesierska-Gadek, J1
Cohen, JB; Kahl, BS; Zain, JM1
Bai, Y; Dai, F; Gai, T; Han, M; He, S; Li, N; Liu, L; Lu, C; Lu, K; Shen, J; Sun, F; Tong, X; Zeng, J1
Chen, Q; Jiang, N; Sun, YF; Zhang, B; Zhang, XM1
Bonaldi, L; Branca, A; Gurrieri, C; Manni, S; Martines, A; Piazza, F; Pizzi, M; Riva, M; Scapinello, G; Semenzato, G; Trentin, L; Visentin, A1

Reviews

1 review(s) available for cytarabine and cyclin d1

ArticleYear
Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2017, Volume: 37

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclin D1; Cytarabine; Gene Expression Regulation, Neoplastic; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell; Prognosis; Rituximab

2017

Other Studies

7 other study(ies) available for cytarabine and cyclin d1

ArticleYear
p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
    Cancer letters, 1998, Jul-17, Volume: 129, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cytarabine; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, Retinoblastoma; Humans; Leukemia; Lymphoma; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; Transcription Factors; Tumor Cells, Cultured; Vincristine; WT1 Proteins

1998
Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents.
    The Journal of cell biology, 1998, Oct-19, Volume: 143, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; CDC2-CDC28 Kinases; Cell Cycle; Cells, Cultured; Cerebral Cortex; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Cytarabine; DNA Damage; Enzyme Activation; Gene Expression Regulation, Viral; Neurons; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Sindbis Virus; Superior Cervical Ganglion; Ultraviolet Rays

1998
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells.
    Leukemia research, 2005, Volume: 29, Issue:11

    Topics: Butyrates; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Valproic Acid

2005
5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Differentiation; research in biological diversity, 2006, Volume: 74, Issue:9-10

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Caspase 7; Cell Cycle; Cell Proliferation; Cyclin D1; Cytarabine; Dimerization; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Receptor, ErbB-2; Tumor Cells, Cultured

2006
Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Cell cycle (Georgetown, Tex.), 2019, Volume: 18, Issue:18

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor Proteins; Cytarabine; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Kidney Neoplasms; Mice; Mice, Nude; Prognosis; S Phase Cell Cycle Checkpoints; Transfection; Up-Regulation

2019
TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:9

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Proliferation; Cells, Cultured; Cyclin D1; Cytarabine; Humans; Leukemia, Myeloid, Acute; MicroRNAs; RNA, Long Noncoding

2020
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
    Annals of hematology, 2020, Volume: 99, Issue:11

    Topics: Abnormal Karyotype; Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Bortezomib; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclin D1; Cytarabine; Drug Resistance, Neoplasm; Fatal Outcome; Gene Duplication; Genes, myc; Humans; Lymphoma, Mantle-Cell; Male; Oncogene Proteins, Fusion; Piperidines; Pyrazoles; Pyrimidines; Recurrence; Rituximab; Translocation, Genetic

2020